Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results. - Moore-Palhares D; Alberico D; Chan AW; DiCenzo D; Sannachi L; Dasgupta A; Yip J; Pena MLA; Gandhi S; Pezo R; Eisen A; Jerzak KJ; et al. (NPJ precision oncology, 2025)